Investigate the effect of the family-centered empowerment model through telenursing on the treatment compliance of coronary artery transplant patients

The purpose of the study is to investigate the effect of the family-centered empowerment model through telenursing on the treatment compliance of coronary artery transplant patients.

Clinical trial with a control group, parallel groups with blinded outcome assessment and data analyzer, randomized, phase 3 on 60 patients. It will be used to randomize the randomization site.

The study site is Imam Ali Hospital in Kermanshah. Before the intervention, questionnaires of treatment compliance and self-efficacy are completed for both groups. In the second stage, the family-centered empowerment model will be implemented for the test group through the Eitaa messenger, and the questionnaires will be completed again for both groups. Blinding in this study is done for the outcome assessor and data analyzer.

Inclusion criteria included performing coronary artery bypass surgery for the first time; having minimum literacy and non-entry criteria, including not using narcotics and psychotropic drugs; Non-participation in the training course is simultaneous with the implementation of the intervention.

30 people in the control group are recipients of rehabilitation center programs. For 30 people in the test group, in addition to the routine programs, a two-hour workshop will be held in the hospital with the aim of familiarizing the participants with the working method and determining the active member of the family. Then, the four stages of the family-centered empowerment model, i.e., threat understanding, problem solving, educational participation, and evaluation through the Eitaa Messenger, will be implemented for 8 weeks.

The primary outcome of the study is adherence to treatment, and the secondary outcome is self-efficacy, which is measured through a questionnaire.

In this study, randomization will be done by the block method through the website www.randomization.com. According to the sample size of 60, 15 blocks of 4 (A, B) will be produced, where A will correspond to the intervention group and B will correspond to the control group. This step will be done by the researcher. In order to hide the resulting blocks, they will be written on a separate card and placed inside 15 opaque envelopes that are identical in appearance, and the order of the sequences will be written on the envelopes. For example, envelope number 1 has a sequence (AABB), and to use them, each envelope will be opened in order of numbering on the envelopes, and the next envelope sequence will not be used until the patients are taken. These envelopes will be given to the expert of the center who is not part of the research group, and then every qualified person will be placed in the intervention or control group by referring to him and removing the envelope.

In this study, it is impossible to implement blinding for the trial participants and for the intervention administrators. However, the person responsible for distributing and collecting questionnaires will not know who is in the intervention or control group, and in other words, blinding will be done for the outcome examiner, and also blinding will be done for the data analyst, in the same order as for the information analyst. The contents of the letters (A, B), which represent the intervention and control groups, will remain hidden.